IRIS
GAUDIO, AGOSTINO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.202
NA - Nord America 2.346
AS - Asia 1.488
SA - Sud America 431
AF - Africa 46
OC - Oceania 6
Totale 7.519
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.285
RU - Federazione Russa 1.760
SG - Singapore 609
CN - Cina 467
BR - Brasile 358
IE - Irlanda 318
SE - Svezia 307
DE - Germania 262
HK - Hong Kong 171
IT - Italia 138
FI - Finlandia 108
FR - Francia 99
VN - Vietnam 92
UA - Ucraina 63
GB - Regno Unito 59
IN - India 49
CA - Canada 26
PL - Polonia 24
AR - Argentina 20
TR - Turchia 16
VE - Venezuela 16
BD - Bangladesh 15
BE - Belgio 15
MX - Messico 15
ES - Italia 14
ZA - Sudafrica 14
IQ - Iraq 13
AT - Austria 8
CO - Colombia 8
JP - Giappone 8
MA - Marocco 8
NL - Olanda 8
CL - Cile 7
PK - Pakistan 7
AU - Australia 6
CZ - Repubblica Ceca 6
PY - Paraguay 6
CI - Costa d'Avorio 5
EC - Ecuador 5
HN - Honduras 5
PE - Perù 5
KE - Kenya 4
LT - Lituania 4
MY - Malesia 4
BO - Bolivia 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
EE - Estonia 3
EG - Egitto 3
GE - Georgia 3
ID - Indonesia 3
IR - Iran 3
JM - Giamaica 3
KG - Kirghizistan 3
KR - Corea 3
NI - Nicaragua 3
OM - Oman 3
UY - Uruguay 3
CR - Costa Rica 2
GT - Guatemala 2
JO - Giordania 2
NG - Nigeria 2
NP - Nepal 2
PH - Filippine 2
PT - Portogallo 2
SA - Arabia Saudita 2
SY - Repubblica araba siriana 2
TN - Tunisia 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BH - Bahrain 1
DM - Dominica 1
ET - Etiopia 1
GA - Gabon 1
HU - Ungheria 1
LK - Sri Lanka 1
LY - Libia 1
MN - Mongolia 1
PS - Palestinian Territory 1
RS - Serbia 1
SC - Seychelles 1
SN - Senegal 1
TT - Trinidad e Tobago 1
UZ - Uzbekistan 1
Totale 7.519
Salva come PNG Salva come JPEG
Città #
Moscow 470
Ashburn 389
Dublin 318
Singapore 315
Chandler 238
Dallas 237
San Jose 173
Nyköping 171
Beijing 149
Munich 147
Jacksonville 146
Hong Kong 145
The Dalles 81
New York 73
Helsinki 61
Los Angeles 55
Lauterbourg 50
Princeton 46
Messina 45
Medford 43
Ann Arbor 37
Ho Chi Minh City 36
Dearborn 34
São Paulo 33
Des Moines 31
Cambridge 30
Boardman 29
Bremen 29
Buffalo 23
Shenyang 22
Tianjin 21
Frankfurt am Main 19
Guangzhou 19
Santa Clara 19
Warsaw 19
Hanoi 18
Brussels 15
Houston 15
Jinan 15
Nanjing 15
Turku 15
Orem 14
Redondo Beach 14
Belo Horizonte 12
Pune 12
Seattle 12
Wilmington 12
Council Bluffs 11
Düsseldorf 11
Johannesburg 11
Catania 10
Chennai 10
Brooklyn 9
Montreal 9
San Mateo 9
Boston 8
Hebei 8
Lancaster 8
Manchester 8
Mumbai 8
Central 7
Denver 7
Nuremberg 7
Poplar 7
Sheung Shui 7
Strasbourg 7
Tokyo 7
Ankara 6
Falls Church 6
Hangzhou 6
Mexico City 6
Shanghai 6
Taiyuan 6
Woodbridge 6
Zhengzhou 6
Abidjan 5
Brno 5
Da Nang 5
Fuzhou 5
Haikou 5
Porto Alegre 5
Rio de Janeiro 5
San Francisco 5
Santiago 5
Shenzhen 5
Baghdad 4
Bauru 4
Brasília 4
Chicago 4
Goiânia 4
Lahore 4
Lappeenranta 4
Lima 4
London 4
Melbourne 4
Nairobi 4
Nanchang 4
Portsmouth 4
Recife 4
Sorocaba 4
Totale 4.249
Salva come PNG Salva come JPEG
Nome #
Effects of a long-term treatment with raloxifene on insulin sensitivity in postmenopausal women 292
AB0819 HANDGRIP STRENGTH PREDICTS HIGH FRACTURE RISK IN PATIENTS WITH TYPE 2 DIABETES MELLITUS 225
Bisphosphonates in the treatment of thalassemia-associated osteoporosis. 220
Effects of strontium ranelate on bone mass and bone turnover in women with thalassemia major-related osteoporosis 216
BONE MASS AND BONE TURNOVER IN WOMEN WITH THALASSEMIA MAJOR RELATED OSTEOPOROSIS: EFFECTS OF STRONTIUM RANELATE 192
Effects of the phytoestrogen genistein on hot flushes, endometrium, and vaginal epithelium in postmenopausal women: a 1-year randomized, double-blind, placebo-controlled study 188
ALENDRONATE TAIL EFFECT ON BONE IS MODULATED BY VITAMIN D: A RETROSPECTIVE STUDY IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS 188
OPG and sRANKL serum concentrations in osteopenic, postmenopausal women after 2-year genistein administration. 182
AB0823 TRABECULAR BONE SCORE AT LUMBAR SPINE IS ASSOCIATED WITH QUANTITATIVE ULTRASOUND MEASUREMENTS AT PHALANGEAL SITE IN BREAST CANCER SURVIVORS RECEIVING AROMATASE INHIBITORS 182
Anxiety levels predict bone mineral density in postmenopausal women undergoing oral bisphosphonates: A two-year follow-up 179
Effects of the phytoestrogen genistein on some predictors of cardiovascular risk in osteopenic, postmenopausal women: A two-year randomized, double-blind, placebo-controlled study 175
Bisphosphonates in the treatment of thalassemia-induced osteoporosis 175
Effects of the phytoestrogen genistein on hot flushes, endometrium and vaginal epithelium in postmenopausal women: a 2-year randomized, double-blind, placebo controlled study. 175
EFFECTS OF DENOSUMAB ON QUANTITATIVE ULTRASOUND AND DUAL-ENERGY X-RAY ABSORPTIOMETRY MEASUREMENTS IN AROMATASE INHIBITOR-TREATED BREAST CANCER WOMEN 172
Long-term hemostatic effects of cholesterol-lowering therapy with atorvastatin 167
TRABECULAR BONE SCORE IS PREDICTED BY PHALANGEAL QUANTITATIVE ULTRASOUND IN BREAST CANCER POSTMENOPAUSAL WOMEN RECEIVING AROMATASE INHIBITORS 163
EFFECTS OF DENOSUMAB ON QUATITATIVE ULTRASOUND AND DXA MEASUREMENTS IN AROMATASE INHIBITOR-TREATED BREAST CANCER WOMEN 163
Bone health in Duchenne muscular dystrophy: clinical and biochemical correlates 156
Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: A randomized double-blind placebo-controlled study 154
Effects of the phytoestrogen genistein on bone metabolism in osteopenic postmenopausal women - A randomized trial 152
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients 151
Hemostasis and fibrinolysis factors in first-degree relatives of patients with type 2 diabetes without hypertension 146
Effects of the phytoestrogen genistein on hot flushes, endometrium and vaginal epithelium in postmenopausal women: a 2-year randomized, double-blind, placebo-controlled study 144
Pain in Osteoporosis: From Pathophysiology to Therapeutic Approach 142
CORRELATION BETWEEN FAMILY HISTORY OF HYPERTENSION AND HAEMOSTATIC DISORDERS 141
Osteoprotegerin and RANKL in the pathogenesis of thalassemia-induced osteoporosis: New pieces of the puzzle 141
Effect of long-term treatment with Raloxifene on mammary density in postmenopausal women. 140
Three-year effectiveness of intravenous pamidronate versus pamidronate plus slow-release sodium fluoride for postmenopausal osteoporosis 139
Early vascular ageing biomarkers in osteoporotic outpatients: a pilot study 138
Osteoporosis and beta-thalassemia major: Role of the IGF- I/IGFBP-III axis 136
Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both 132
Trabecular bone score and quantitative ultrasound measurements in the assessment of bone health in breast cancer survivors assuming aromatase inhibitors 132
Effetti del raloxifene sulla secrezione ipofisaria in post-menopausa 131
Renal function is associated with changes in bone mineral density in postmenopausal osteoporotic women treated with Denosumab: data from a retrospective cohort study 129
HANDGRIP STRENGTH TO DISCRIMINATE HIGH FRACTURE RISK IN TYPE 2 DIABETES MELLITUS PATIENTS 129
Clinical and molecular description of the first Italian cohort of 33 subjects with hypophosphatasia 127
Early Changes of VEGF Levels After Zoledronic Acid in Women With Postmenopausal Osteoporosis: A Potential Role of Vitamin D 124
Sclerostin is a possible candidate marker of arterial stiffness: Results from a cohort study in Catania 122
Randomized, double-blind, placebo-controlled study on effects of raloxifene and hormone replacement therapy on plasma NO concentrations, endothelin-1 levels, and endothelium-dependent vasodilation in postmenopausal women 119
VITAMIN D PROMOTES BONE MINERAL DENSITY ACCRUAL AFTER DISCONTINUATION OF ALENDRONATE 111
Effects of hormonal replacement therapy on bone metabolism in young adults with beta-thalassemia major 109
Familiar osteopoikilosis: Case report with differential diagnosis and review of the literature 104
Pharmacological management of severe postmenopausal osteoporosis 103
Underdiagnosis and undertreatment of osteoporotic patients admitted in internal medicine wards in Italy between 2010 and 2016 (the REPOSI Register) 99
Pathogenesis of Thalassemia Major-Associated Osteoporosis: Review of the Literature and Our Experience 98
Menopause modulates homocysteine levels in diabetic and non-diabetic women. 96
Metabolic effects of dehydroepiandrosterone replacement therapy in postmenopausal women 86
Calf circumference predicts changes of bone mineral density in postmenopausal osteoporotic women receiving denosumab 83
POS1119 A SINGLE DOSE OF ZOLEDRONATE INDUCES MODIFICATIONS OF SERUM VEGF IN OSTEOPOROTIC POSTMENOPAUSAL WOMEN 79
Quantitative ultrasound and DXA measurements in aromatase inhibitor-treated breast cancer women receiving denosumab 75
Exploring the Association Between Platelet Count, the Systemic Immune Inflammation Index, and Fracture Risk in Postmenopausal Women with Osteoporosis: A Cross-Sectional Study 74
IMPACT OF ANXIETY LEVELS ON BONE MINERAL DENSITY IN POSTMENOPAUSAL WOMEN TREATED WITH ORAL BIPHOSPHONATES: RESULTS FROM A LONGITUDINAL COHORT STUDY 74
Pain in Osteoporosis: Current and Future Strategies 68
Osteoporosis and Fragility Fractures in Type 2 Diabetes 30
null 21
null 21
Totale 7.610
Salva come PNG Salva come JPEG
Categoria #
all - tutte 24.367
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.367
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20217 0 0 0 0 0 0 0 0 0 0 0 7
2021/2022414 1 63 14 7 14 6 48 12 32 76 36 105
2022/2023945 62 110 51 53 79 94 10 63 376 12 21 14
2023/2024299 20 39 15 28 14 81 4 39 0 11 14 34
2024/20251.305 29 21 17 83 56 81 75 219 314 91 119 200
2025/20263.982 212 261 244 243 333 816 457 572 567 156 58 63
Totale 7.610